Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

['lizbeth]

Paul,

Hopefully you will be overwhelmed keeping up with new cancer treatments over the next few years! Did you see all the treatments in the pipeline at Novartis?

I searched for Neoadjuvant trials a few months ago at clinicaltrials.gov and was just blown away at how many there were.

When do you expect any treatments that use targets other than the HER1-4 or ER+ to be approved?